Estimating treatment effects with treatment switching via semicompeting risks models: an application to a colorectal cancer study (Q3224224)

From MaRDI portal
Revision as of 19:19, 13 March 2024 by Daniel (talk | contribs) (‎Created claim: MaRDI profile type (P1460): MaRDI publication profile (Q5976449), #quickstatements; #temporary_batch_1710346383791)
scientific article
Language Label Description Also known as
English
Estimating treatment effects with treatment switching via semicompeting risks models: an application to a colorectal cancer study
scientific article

    Statements

    Estimating treatment effects with treatment switching via semicompeting risks models: an application to a colorectal cancer study (English)
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    29 March 2012
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    expectation-maximization algorithm
    0 references
    maximum likelihood estimate
    0 references
    noncompliance
    0 references
    panitumumab
    0 references
    partial switching
    0 references
    transition model
    0 references
    0 references